2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.
暂无分享,去创建一个
T. Smutny | P. Pávek | J. Kuneš | M. Pour | Z. Hrušková | Lucie Hyršová | A. Carazo | M. Spulak | Marcela Drechslerová | Alice Nová
[1] Taosheng Chen,et al. Small-molecule modulators of PXR and CAR. , 2016, Biochimica et biophysica acta.
[2] T. Smutny,et al. The pregnane X receptor down‐regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for (“squelching”) SRC‐1 coactivator , 2016, British journal of pharmacology.
[3] Alejandro Carazo,et al. The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists , 2015, Sensors.
[4] Johanna Jyrkkärinne,et al. An update on the constitutive androstane receptor (CAR) , 2013, Drug metabolism and drug interactions.
[5] L. Perera,et al. Phenobarbital Indirectly Activates the Constitutive Active Androstane Receptor (CAR) by Inhibition of Epidermal Growth Factor Receptor Signaling , 2013, Science Signaling.
[6] J. Pourová,et al. The unambiguous synthesis and NMR assignment of 4-alkoxy and 3-alkylquinazolines , 2013 .
[7] Xianqing Deng,et al. Synthesis and Anticonvulsant Activity Evaluation of 5‐Phenyl‐[1,2,4]triazolo[4,3‐c]quinazolin‐3‐amines , 2013, Archiv der Pharmazie.
[8] Menghang Xia,et al. Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches , 2012, Pharmaceutical Research.
[9] W. Xie,et al. Targeting xenobiotic receptors PXR and CAR for metabolic diseases. , 2012, Trends in pharmacological sciences.
[10] M. Schwab,et al. Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms , 2012, British journal of pharmacology.
[11] D. Nie,et al. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. , 2012, Biochemical pharmacology.
[12] Robert Barouki,et al. The aryl hydrocarbon receptor system , 2012, Drug metabolism and drug interactions.
[13] T. Laitinen,et al. Use of comprehensive screening methods to detect selective human CAR activators. , 2011, Biochemical pharmacology.
[14] A. Poso,et al. New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists. , 2011, Molecular pharmaceutics.
[15] Jianguang Zhou,et al. One-pot synthesis of quinazolinones via iridium-catalyzed hydrogen transfers. , 2011, The Journal of organic chemistry.
[16] M. Negishi,et al. Active ERK1/2 Protein Interacts with the Phosphorylated Nuclear Constitutive Active/Androstane Receptor (CAR; NR1I3), Repressing Dephosphorylation and Sequestering CAR in the Cytoplasm* , 2011, The Journal of Biological Chemistry.
[17] T. Misaka,et al. Polyphenols in Alcoholic Beverages Activating Constitutive Androstane Receptor CAR , 2011, Bioscience, biotechnology, and biochemistry.
[18] P. Pávek,et al. The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. , 2011, Current pharmaceutical biotechnology.
[19] Laura Hamel,et al. Modulation of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) by 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives, ligands of peripheral benzodiazepine receptor (PBR). , 2011, Toxicology letters.
[20] Z. Dvořák,et al. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. , 2011, Current drug metabolism.
[21] Z. Dvořák,et al. Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug‐metabolizing cytochrome P450 enzymes , 2010, Journal of thrombosis and haemostasis : JTH.
[22] Z. Dvořák,et al. Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids , 2010, Drug metabolism reviews.
[23] P. Ascenzi,et al. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. , 2009, Molecular aspects of medicine.
[24] Wen Xie,et al. PXR and CAR in energy metabolism , 2009, Trends in Endocrinology & Metabolism.
[25] W. S. Baldwin,et al. Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. , 2009, Current pharmacogenomics and personalized medicine.
[26] Johanna Jyrkkärinne,et al. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship. , 2008, Journal of medicinal chemistry.
[27] Z. Dvořák,et al. Azole Antimycotics Differentially Affect Rifampicin-Induced Pregnane X Receptor-Mediated CYP3A4 Gene Expression , 2008, Drug Metabolism and Disposition.
[28] J. Pascussi,et al. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. , 2008, Annual review of pharmacology and toxicology.
[29] M. Trauner,et al. Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors. , 2007, Molecular pharmaceutics.
[30] Bradley L Urquhart,et al. Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs , 2007, Journal of clinical pharmacology.
[31] Hongbing Wang,et al. Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers , 2007, Journal of Pharmacology and Experimental Therapeutics.
[32] Wen Xie,et al. International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor , 2006, Pharmacological Reviews.
[33] M. Redinbo,et al. Orphan nuclear receptors adopted by crystallography. , 2005, Current opinion in structural biology.
[34] S. Auerbach,et al. Retinoid X Receptor-α-Dependent Transactivation by a Naturally Occurring Structural Variant of Human Constitutive Androstane Receptor (NR1I3) , 2005, Molecular Pharmacology.
[35] Oliver Burk,et al. Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor , 2005, Molecular Pharmacology.
[36] L. Moore,et al. A Structural Basis for Constitutive Activity in the Human CAR/RXRα Heterodimer , 2004 .
[37] S. Auerbach,et al. Alternatively spliced isoforms of the human constitutive androstane receptor. , 2003, Nucleic acids research.
[38] L. Moore,et al. Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes* , 2003, The Journal of Biological Chemistry.
[39] L. Moore,et al. The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.
[40] D. Moore,et al. The Xenobiotic Compound 1,4-Bis[2-(3,5-Dichloropyridyloxy)]Benzene Is an Agonist Ligand for the Nuclear Receptor CAR , 2000, Molecular and Cellular Biology.
[41] B. Bandgar. Synthesis of Quinazolin-4-(3h)-ones from O-Amidobenzonitriles Using Urea-hydrogen Peroxide1 , 1997 .